Epidemiology, clinical features, and outcome of the hospitalized patients with Kerion in Fars Province, Iran: an eleven-year retrospective study.


Journal

BMC pediatrics
ISSN: 1471-2431
Titre abrégé: BMC Pediatr
Pays: England
ID NLM: 100967804

Informations de publication

Date de publication:
31 Oct 2024
Historique:
received: 06 08 2024
accepted: 22 10 2024
medline: 1 11 2024
pubmed: 1 11 2024
entrez: 1 11 2024
Statut: epublish

Résumé

Kerion, a severe inflammatory type of tinea capitis, presents with purulent, boggy swelling and alopecia. Few articles in the literature provide information on this uncommon manifestation of tinea capitis (TC). This study aimed to determine the epidemiological and clinical characteristics of patients with Kerion over an 11-year period in an inpatient setting. In this retrospective cross-sectional study, we enrolled all the admitted patients with inflammatory TC in the dermatology department of Shahid Faghihi referral hospital during 2011-2022. The data included demographic factors, animal contact, treatment, outcome, and past medical profiles. We used STATA 14.2 to analyze the data. One hundred and thirty-two patients with Kerion were enrolled in to the study. the mean age of patients was 7.6 ± 5.8 years. Boys (82.5%, n = 109) significantly outnumbered girls (17.5%, n = 23), and 82.2% of patients were under 11 years of age. Eight patients were one to two years old, two were infants under one year old, and five were adults. More than half (52.2%) of the patients were from rural areas. Most of the cases had heavily utilized systemic antifungal therapy, antibiotics, and corticosteroids. In addition, 43 patients reported positive animal contact. Over the course of an eleven-year period, there was a downward trend in the number of hospitalized patients. We report one of the largest studies on Kerion patients over an eleven-year period. We have expanded the information on Kerion patients' epidemiology, transmission mode, and clinical outcomes. To develop preventative strategies for Kerion, future studies should focus on additional risk factors and individual susceptibilities.

Sections du résumé

BACKGROUND BACKGROUND
Kerion, a severe inflammatory type of tinea capitis, presents with purulent, boggy swelling and alopecia. Few articles in the literature provide information on this uncommon manifestation of tinea capitis (TC). This study aimed to determine the epidemiological and clinical characteristics of patients with Kerion over an 11-year period in an inpatient setting.
METHODS METHODS
In this retrospective cross-sectional study, we enrolled all the admitted patients with inflammatory TC in the dermatology department of Shahid Faghihi referral hospital during 2011-2022. The data included demographic factors, animal contact, treatment, outcome, and past medical profiles. We used STATA 14.2 to analyze the data.
RESULTS RESULTS
One hundred and thirty-two patients with Kerion were enrolled in to the study. the mean age of patients was 7.6 ± 5.8 years. Boys (82.5%, n = 109) significantly outnumbered girls (17.5%, n = 23), and 82.2% of patients were under 11 years of age. Eight patients were one to two years old, two were infants under one year old, and five were adults. More than half (52.2%) of the patients were from rural areas. Most of the cases had heavily utilized systemic antifungal therapy, antibiotics, and corticosteroids. In addition, 43 patients reported positive animal contact. Over the course of an eleven-year period, there was a downward trend in the number of hospitalized patients.
CONCLUSION CONCLUSIONS
We report one of the largest studies on Kerion patients over an eleven-year period. We have expanded the information on Kerion patients' epidemiology, transmission mode, and clinical outcomes. To develop preventative strategies for Kerion, future studies should focus on additional risk factors and individual susceptibilities.

Identifiants

pubmed: 39482618
doi: 10.1186/s12887-024-05171-6
pii: 10.1186/s12887-024-05171-6
doi:

Substances chimiques

Antifungal Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

694

Informations de copyright

© 2024. The Author(s).

Références

Gupta AK, Mays RR, Versteeg SG, Piraccini BM, Shear NH, Piguet V, et al. Tinea capitis in children: a systematic review of management. J Eur Acad Dermatol Venereol. 2018;32(12):2264–74. https://doi.org/10.1111/jdv.15088 .
doi: 10.1111/jdv.15088 pubmed: 29797669
Leung AKC, Hon KL, Leong KF, Barankin B, Lam JM. Tinea Capitis: an updated review. Recent Pat Inflamm Allergy Drug Discov. 2020;14(1):58–68. https://doi.org/10.2174/1872213x14666200106145624 .
doi: 10.2174/1872213x14666200106145624 pubmed: 31906842
John AM, Schwartz RA, Janniger CK. The kerion: an angry tinea capitis. Int J Dermatol. 2018;57(1):3–9. https://doi.org/10.1111/ijd.13423 .
doi: 10.1111/ijd.13423 pubmed: 27696388
Urbanek M, Neill SM, Miller JA. Kerion–a case report. Clin Exp Dermatol. 1995;20(5):413–4. https://doi.org/10.1111/j.1365-2230.1995.tb01360.x .
doi: 10.1111/j.1365-2230.1995.tb01360.x pubmed: 8593720
Tran TH, Van Hoang N. The results of the hospitalized treatment of Kerion Celsi. Open Access Macedonian J Med Sci. 2023;11(B):489–93. https://doi.org/10.3889/oamjms.2023.11575 .
doi: 10.3889/oamjms.2023.11575
Zhan P, Geng C, Li Z, Jin Y, Jiang Q, Tao L, et al. Evolution of tinea capitis in the Nanchang area, Southern China: a 50-year survey (1965–2014). Mycoses. 2015;58(5):261–6. https://doi.org/10.1111/myc.12307 .
doi: 10.1111/myc.12307 pubmed: 25756741
Zaraa I, Hawilo A, Aounallah A, Trojjet S, El Euch D, Mokni M, Ben Osman A. Inflammatory tinea capitis: a 12-year study and a review of the literature. Mycoses. 2013;56(2):110–6. https://doi.org/10.1111/j.1439-0507.2012.02219.x .
doi: 10.1111/j.1439-0507.2012.02219.x pubmed: 22757767
Bennassar A, Grimalt R. Management of tinea capitis in childhood. Clin Cosmet Investig Dermatol. 2010;3:89–98. https://doi.org/10.2147/ccid.s7992 .
doi: 10.2147/ccid.s7992 pubmed: 21437064 pmcid: 3047946
Padilha-Gonçalves A. Inflammatory tinea capitis (kerion) mimicking dissecting cellulitis. Int J Dermatol. 1992;31(1):66. https://doi.org/10.1111/j.1365-4362.1992.tb03526.x .
doi: 10.1111/j.1365-4362.1992.tb03526.x pubmed: 1737695
Abastabar M, Babaei M, Mohammadi R, Valadan R, Javidnia J, Zaedi A, et al. Iranian National Survey on Tinea Capitis: Antifungal Susceptibility Profile, Epidemiological Characteristics, and Report of two strains with a Novel mutation in SQLE Gene with Homology modeling. Mycopathologia. 2023;188(5):449–60. https://doi.org/10.1007/s11046-022-00657-2 .
doi: 10.1007/s11046-022-00657-2 pubmed: 35980496
Gracia-Cazaña T, Milagro A, Rezusta A, Gilaberte Y. [Kerion of the vulva: a common pathology in an unusual location]. Revista Iberoamericana De Micologia. 2017;34(2):123–5. https://doi.org/10.1016/j.riam.2016.11.003 .
doi: 10.1016/j.riam.2016.11.003 pubmed: 28363488
Xia X, Zhi H, Liu Z, Shen H. Adult kerion caused by Trichophyton rubrum in a vegetarian woman with onychomycosis. Clin Microbiol Infection: Official Publication Eur Soc Clin Microbiol Infect Dis. 2023;29(2):188–9. https://doi.org/10.1016/j.cmi.2022.07.029 .
doi: 10.1016/j.cmi.2022.07.029
Zhou YB, Chao JJ, Ma L, Xiao YY. Kerion caused by Trichophyton tonsurans in an infant. Int J Infect Diseases: IJID : Official Publication Int Soc Infect Dis. 2021;102:242–3. https://doi.org/10.1016/j.ijid.2020.11.144 .
doi: 10.1016/j.ijid.2020.11.144
Fuller LC, Barton RC, Mohd Mustapa MF, Proudfoot LE, Punjabi SP, Higgins EM. British Association of Dermatologists’ guidelines for the management of tinea capitis 2014. Br J Dermatol. 2014;171(3):454–63. https://doi.org/10.1111/bjd.13196 .
doi: 10.1111/bjd.13196 pubmed: 25234064
Proudfoot LE, Higgins EM, Morris-Jones R. A retrospective study of the management of pediatric kerion in Trichophyton tonsurans infection. Pediatr Dermatol. 2011;28(6):655–7. https://doi.org/10.1111/j.1525-1470.2011.01645.x .
doi: 10.1111/j.1525-1470.2011.01645.x pubmed: 22082462
Grijsen ML, de Vries HJC, Kerion. CMAJ: Canadian Medical Association journal = journal de l’Association medicale canadienne. 2017;189(20):E725 https://doi.org/10.1503/cmaj.160665
Cruciani D, Papini M, Broccatelli S, Agnetti F, Spina S, Natalini Y, Crotti S. Presumptive zoonotic kerion by Nannizzia Gypsea: Case Report. Front Veterinary Sci. 2021;8:718766. https://doi.org/10.3389/fvets.2021.718766 .
doi: 10.3389/fvets.2021.718766
Martínez-Ortega JI, Ramirez Cibrian AG, Fernández-Reyna I, Atoche Dieguez CE. Tinea Capitis Kerion type in three siblings caused by Nannizzia Gypsea. Cureus. 2024;16(3):e55485. https://doi.org/10.7759/cureus.55485 .
doi: 10.7759/cureus.55485 pubmed: 38571824 pmcid: 10988543
Toyosawa Y, Kimura U, Kurihara M, Noguchi H, Matsumoto T, Hiruma M, et al. Kerion Celsi caused by Nannizzia Gypsea in a two-year-old child who had been hospitalized since birth. Med Mycol J. 2022;63(1):21–3. https://doi.org/10.3314/mmj.21-00021 .
doi: 10.3314/mmj.21-00021 pubmed: 35228482
Aste N, Pinna AL, Pau M, Biggio P. Kerion Celsi in a newborn due to Microsporum canis. Mycoses. 2004;47(5–6):236–7. https://doi.org/10.1111/j.1439-0507.2004.00967.x .
doi: 10.1111/j.1439-0507.2004.00967.x pubmed: 15189191
Feuerman EJ, Alteras I, Léhrer N. Kerion-like tinea capitis and barbae caused by Microsporum Gypseum in Israel. Mycopathologia. 1976;58(3):165–8. https://doi.org/10.1007/bf00496025 .
doi: 10.1007/bf00496025 pubmed: 967226
del Boz J, Crespo V, Rivas-Ruiz F, de Troya M. A 30-year survey of paediatric tinea capitis in southern Spain. J Eur Acad Dermatol Venereol. 2011;25(2):170–4. https://doi.org/10.1111/j.1468-3083.2010.03733.x .
doi: 10.1111/j.1468-3083.2010.03733.x pubmed: 20553362
Afshar P, Vahedi L, Ghasemi M, Mardanshahi A. Epidemiology of tinea capitis in northeast Iran: a retrospective analysis from 1998 to 2012. Int J Dermatol. 2016;55(6):640–4. https://doi.org/10.1111/ijd.12888 .
doi: 10.1111/ijd.12888 pubmed: 26440755
Emele FE, Oyeka CA. Tinea capitis among primary school children in Anambra state of Nigeria. Mycoses. 2008;51(6):536–41. https://doi.org/10.1111/j.1439-0507.2008.01507.x .
doi: 10.1111/j.1439-0507.2008.01507.x pubmed: 18422917
Bassiri Jahromi S, Khaksar AA. Aetiological agents of tinea capitis in Tehran (Iran). Mycoses. 2006;49(1):65–7. https://doi.org/10.1111/j.1439-0507.2005.01182.x .
doi: 10.1111/j.1439-0507.2005.01182.x pubmed: 16367822
Wang HN, Shang CS, Yang SJ, Shih IH, Hui CR, Yang CY, et al. Clinical and epidemiological characteristics of tinea capitis in northern Taiwan during 2014–2019: an unusual bimodal distribution of patients and comparison of paediatric and adult cases. Mycoses. 2021;64(5):484–94. https://doi.org/10.1111/myc.13234 .
doi: 10.1111/myc.13234 pubmed: 33368733
Peres NT, Maranhão FC, Rossi A, Martinez-Rossi NM. Dermatophytes: host-pathogen interaction and antifungal resistance. An Bras Dermatol. 2010;85(5):657–67. https://doi.org/10.1590/s0365-05962010000500009 .
doi: 10.1590/s0365-05962010000500009 pubmed: 21152790
Ogawa H, Summerbell RC, Clemons KV, Koga T, Ran YP, Rashid A, et al. Dermatophytes and host defence in cutaneous mycoses. Med Mycol. 1998;36(Suppl 1):166–73.
pubmed: 9988505
Ba O, Kébé M, Groun SA, Sy O, Sidiya MA, Eibih ABA, et al. Epidemiology of scalp ringworms and superficial fungal infections in schools in Mauritania. Tunis Med. 2021;99(12):1126–33.
pubmed: 35288918 pmcid: 8974423
Mtibaa L, Rabhi F, Abderrahim A, Baccouchi N, Jaber K, Fares H, et al. [Tinea capitis: epidemiological study in Tunis from 2012 to 2020]. Pan Afr Med J. 2022;41:168. https://doi.org/10.11604/pamj.2022.41.168.29473 .
doi: 10.11604/pamj.2022.41.168.29473 pubmed: 35655683 pmcid: 9120736
Yamasaki Y, Toda M, Ikutomi M, Nishikawa T. An adult case of kerion Celsi due to Trichophyton tonsurans. J Dermatol. 1982;9(6):445–9. https://doi.org/10.1111/j.1346-8138.1982.tb01087.x .
doi: 10.1111/j.1346-8138.1982.tb01087.x pubmed: 6763047
Alteraş I, Roşu P. Unusual localisation of Kerion Celsi in adult. Mykosen. 1969;12(10):607–9. https://doi.org/10.1111/j.1439-0507.1969.tb03414.x .
doi: 10.1111/j.1439-0507.1969.tb03414.x pubmed: 5407940
Shimoyama H, Taira H, Satoh K, Tamura T, Yo A, Sei Y, et al. Kerion Celsi due to Microsporum canis in an adult woman, treated successfully with Fosravuconazole. Med Mycol J. 2023;64(2):37–43. https://doi.org/10.3314/mmj.22-00025 .
doi: 10.3314/mmj.22-00025 pubmed: 37258133
Aguirre Sotelo JP, Tarango Martinez VM, Vera Cabrera L. Kerion celsi caused by Trichophyton tonsurans in an adult. An Bras Dermatol. 2022;97(5):637–40. https://doi.org/10.1016/j.abd.2021.10.005 .
doi: 10.1016/j.abd.2021.10.005 pubmed: 35850939 pmcid: 9453518
Ye QR, Luo YW, Zhou X, Li QQ, Liu YM. Adult Kerion Celsi caused by Trichophyton tonsurans secondary to black dot Tinea Capitis. Mycopathologia. 2023;188(5):589–91. https://doi.org/10.1007/s11046-022-00701-1 .
doi: 10.1007/s11046-022-00701-1 pubmed: 36617365 pmcid: 10564823
Pomeranz AJ, Sabnis SS. Tinea capitis: epidemiology, diagnosis and management strategies. Paediatr Drugs. 2002;4(12):779–83. https://doi.org/10.2165/00128072-200204120-00002 .
doi: 10.2165/00128072-200204120-00002 pubmed: 12431130
Keipert JA. Beneficial effect of corticosteroid therapy in microsporum canis kerion. Australas J Dermatol. 1984;25(3):127–30. https://doi.org/10.1111/j.1440-0960.1984.tb00830.x .
doi: 10.1111/j.1440-0960.1984.tb00830.x pubmed: 6534374
Nichter LS, Thomas DM, Atkinson J, Reinisch JF, Sloan GM. Scalp infections in black children: think kerion. Plast Reconstr Surg. 1987;80(5):717–9. https://doi.org/10.1097/00006534-198711000-00012 .
doi: 10.1097/00006534-198711000-00012 pubmed: 3671565

Auteurs

Fateme Khosravi (F)

Student Research Committee, Shiraz University of Medical Sciences, Shiraz, Iran.

Mohammad Mahdi Parvizi (MM)

Molecular Dermatology Research Center, Shiraz University of Medical Sciences, Shiraz, Iran. mmparvizi@gmail.com.
Vice Chancellor of Academic Affairs, Smart University of Medical Sciences, Tehran, Iran. mmparvizi@gmail.com.

Maryam Sadat Sadati (MS)

Molecular Dermatology Research Center, Department of Dermatology, Shiraz University of Medical Sciences, Shiraz, Iran.

Mohammadreza Khosravi (M)

Noncommunicable Diseases Research Center, Fasa University of Medical Sciences, Fasa, Iran.

Mehdi Ghahartars (M)

Molecular Dermatology Research Center, Department of Dermatology, Shiraz University of Medical Sciences, Shiraz, Iran.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH